Intravenous human immunoglobulins for refractory recurrent pericarditis: A systematic review of all published cases

Journal of Cardiovascular Medicine

Volumn 17, Issue 4, 2016, Pages 263-269

  Imazio, Massimo ^a   Lazaros, George ^a,b   Picardi, Elisa ^a   Vasileiou, Panagiotis ^b   Carraro, Mara ^a   Tousoulis, Dimitrios ^b   Belli, Riccardo ^b   Gaita, Fiorenzo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Human intravenous immunoglobulin; Prognosis; Recurrent pericarditis; Therapy

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL PRODUCT; COLCHICINE; CORTICOSTEROID; HUMAN IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; IMMUNOGLOBULIN;

AUTOIMMUNE DISEASE; DISEASE DURATION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; INFECTION; INFLAMMATORY DISEASE; PERICARDITIS; RECURRENCE FREE SURVIVAL; RECURRENT DISEASE; REFRACTORY RECURRENT PERICARDITIS; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; PERICARDITIS; RECURRENCE;

EID: 84960087337     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000260     Document Type: Review

References (22)

1. Imazio M, Brucato A, Cemin R, et al. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med 2011; 155:409-414.
2. Imazio M, Brucato A, Belli R, et al. Colchicine for the prevention of pericarditis: what we know and what we do not know in 2014: systematic review and meta-analysis. J Cardiovasc Med (Hagerstown) 2014; 15:840-846; [Epub ahead of print].
3. Del Fresno MR, Peralta JE, Granados MA, et al. Intravenous immunoglobulin therapy for refractory recurrent pericarditis. Pediatrics 2014; 134:e1441-e1446.
4. Moretti M, Buiatti A, Merlo M, et al. Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. Am J Cardiol 2013; 112:1493-1498.
5. Rubach MP, Pavlisko EN, Perfect JR. Pericarditis mediated by respiratory syncytial virus in a hematopoietic stem cell transplant patient. Transpl Infect Dis 2013; 15:E152-E156.
6. Baszis KW, Singh G, White A, Thatayatikom A. Recurrent cardiac tamponade in a child with newly diagnosed systemic-onset juvenile idiopathic arthritis. J Clin Rheumatol 2012; 18:304-346.
7. Park IH, Choi du Y, Oh YK, et al. A case of acute myopericarditis associated with Mycoplasma pneumoniae infection in a child. Korean Circ J 2012; 42:709-713.
8. Aizawa-Yashiro T, Oki E, Tsuruga K, et al. Intravenous immunoglobulin therapy leading to dramatic improvement in a patient with systemic juvenile idiopathic arthritis and severe pericarditis resistant to steroid pulse therapy. Rheumatol Int 2012; 32:1359-1361.
9. Watanabe S, Aizawa-Yashiro T, Tsuruga K, et al. Successful multidrug treatment of a pediatric patient with severe Churg-Strauss syndrome refractory to prednisolone. Tohoku J Exp Med 2011; 225:117-121.
10. Kao KL, Yeh SJ, Chen CC. Myopericarditis associated with varicella zoster virus infection. Pediatr Cardiol 2010; 31:703-706.
11. Suesaowalak M, Cheung MM, Tucker D, et al. Chlamydophila pneumoniae myopericarditis in a child. Pediatr Cardiol 2009; 30:336-339.
12. Neto NS, Waldrich L, de Carvalho JF, Pereira RM. Adult-onset Still's disease with pulmonary and cardiac involvement and response to intravenous immunoglobulin. Acta Reumatol Port 2009; 34:628-632.
13. Wendelin G, Fandl A, Beitzke A. High-dose intravenous immunoglobulin in recurrent postpericardiotomy syndrome. Pediatr Cardiol 2008; 29:463-464.
14. Sonçagi A, Devrim I, Karagöz T, et al. Septated pericarditis associated with Kawasaki disease: a brief case report. Turk J Pediatr 2007; 49:312-314.
15. Peterlana D, Puccetti A, Simeoni S, et al. Efficacy of intravenous immunoglobulin in chronic idiopathic pericarditis: report of four cases. Clin Rheumatol 2005; 24:18-21.
16. Bennett AN, Peterson P, Sangle S, et al. Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Rheumatology 2004; 43:795-799.
17. Grenader T, Shavit L. Intravenous immunoglobulin in treatment of cardiac tamponade in a patient with systemic lupus erythematosus. Clin Rheumatol 2004; 23:530-532.
18. Tona F, Bellotto F, Laveder F, et al. Efficacy of high-dose intravenous immunoglobulins in two patients with idiopathic recurrent pericarditis refractory to previous immunosuppressive treatment. Ital Heart J 2003; 4:64-68.
19. Meissner M, Sherer Y, Levy Y, et al. Intravenous immunoglobulin therapy in a patient with lupus serositis and nephritis. Rheumatol Int 2000; 19:199-201.
20. Zandman-Goddard G, Levy Y, Shoenfeld Y. Intravenous immunoglobulin therapy and systemic lupus erythematosus. Clin Rev Allergy Immunol 2005; 29:219-228.
21. Richter C, Schnabel A, Csernok E, et al. Treatment of antineutrophil cytoplasmic antibody (ANCA)-associated systemi vasculitis with high-dose intravenous immunoglobulin. Clin Exp Immunol 1995; 101:2-7.
22. Gelfand EW. Intravenous immune globulin inautoimmune and inflammatory diseases. N Engl J Med 2012; 367:2015-2025.